For instance, GPR30‐deficient mice exhibited reduced inflammation, while inhibition or knockdown of GPR30 significantly alleviated rosacea‐like inflammation in LL37 or LL37 plus E2‐treated models, indicating that activation of the E2/GPR30 signaling pathway plays a critical role in the inflammatory process [32]. The gene discussed is GPER1; the disease is rosacea.